Rite Aid Expands No-Charge COVID-19 Testing to All Drive-Through Locations
February 11 2021 - 9:15AM
Business Wire
Rite Aid Surpasses 1,200 Testing Sites in
Partnership with HHS
Rite Aid (NYSE: RAD) is expanding no-charge COVID-19 self-swab
testing to all drive-through locations, with 441 additional sites
opening Friday, February 12, through its partnership with the U.S.
Department of Health and Human Services (HHS).
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20210211005571/en/
The new testing sites will increase Rite Aid's capacity for
COVID-19 testing services in California, Connecticut, Delaware,
Idaho, Maryland, Michigan, New Hampshire, Ohio, Oregon, Virginia
and Washington.
Like Rite Aid's existing drive-through testing sites, the new
locations will utilize PCR, simple self-swab nasal tests overseen
by Rite Aid pharmacists and will operate Monday through Friday 10
a.m. - 8 p.m. and Saturday and Sunday 10 a.m. - 5 p.m. Rite Aid's
COVID-19 nasal tests are available for all individuals four years
of age and older, regardless if they are experiencing virus
symptoms, in accordance with the Centers for Disease Control and
Prevention (CDC) guidance.
At all testing locations, customers are required to pre-register
online at www.riteaid.com in order to schedule a time slot for
testing. Individuals ages 4-17 may access testing with parent or
legal guardian consent. Additionally, a parent or legal guardian
must be in attendance and bring their photo ID to the testing
appointment with the minor.
Now operating more than 1,200 testing sites across 16 states,
Rite Aid is expanding access to essential testing services across
more communities while ensuring the safety of in-store customers by
offering testing exclusively via the drive-through. A complete list
of Rite Aid's COVID-19 testing sites can also be found at
www.riteaid.com.
“Testing is an essential tool in the battle against COVID-19,”
said Jocelyn Konrad, executive vice president and chief pharmacy
officer, Rite Aid. “With the distribution of COVID-19 vaccines
ramping up, it’s imperative that getting tested remains a priority
with other COVID-19 safety prevention methods.”
Rite Aid partners with Verily and its Baseline COVID-19 Testing
Program to provide screening, scheduling and return of results to
participants for Rite Aid testing sites.
BioReference Laboratories provides COVID-19 laboratory
testing.
Clinical oversight for the COVID-19 testing program is provided
by PWNHealth, a national clinician network that enables safe and
easy access to diagnostic testing.
Rite Aid will continue to provide regular updates on the
company's progress with COVID-19 testing.
About Rite Aid Corporation
Rite Aid Corporation is on the front lines of delivering
healthcare services and retail products to more than 1.6 million
Americans daily. Our pharmacists are uniquely positioned to engage
with customers and improve their health outcomes. We provide an
array of whole being health products and services for the entire
family through over 2,400 retail pharmacy locations across 17
states. Through Elixir, we provide pharmacy benefits and services
to approximately 4 million members nationwide. For more
information, www.riteaid.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210211005571/en/
MEDIA: Chris Savarese 717-975-5718
christopher.savarese@riteaid.com
Rite Aid (NYSE:RAD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Rite Aid (NYSE:RAD)
Historical Stock Chart
From Apr 2023 to Apr 2024